In the published article, there was an error in Figures 6B, 7G as published. In Figure 6B, the image of Group 20 μM (cells treated with 20 μM of HF) of Transwell invasion assay was wrongly used in the original article during the figure assembly process. In Figure 7G, we recognized by ourselves that the H&E staining images of heart, liver, and spleen tissues of nude mice in Group 50 mg/kg were misused. The corrected Figures 6, 7 appear below.
Figure 6
Figure 7
The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
esophageal cancer, hinokiflavone, apoptosis, KEGG analysis, molecular docking, PI3K/AKT/mTOR signal pathway
Citation
Guo J, Zhang S, Wang J, Zhang P, Lu T and Zhang L (2022) Corrigendum: Hinokiflavone Inhibits Growth of Esophageal Squamous Cancer By Inducing Apoptosis via Regulation of the PI3K/AKT/mTOR Signaling Pathway. Front. Oncol. 12:970020. doi: 10.3389/fonc.2022.970020
Received
15 June 2022
Accepted
16 June 2022
Published
05 July 2022
Volume
12 - 2022
Edited and reviewed by
Zhe-Sheng Chen, St. John’s University, United States
Updates
Copyright
© 2022 Guo, Zhang, Wang, Zhang, Lu and Zhang.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Linyou Zhang, lyzhang@hrbmu.edu.cn
†These authors have contributed equally to this work
This article was submitted to Cancer Molecular Targets and Therapeutics, a section of the journal Frontiers in Oncology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.